Alliancebernstein L.P. Harmony Biosciences Holdings, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 152,340 shares of HRMY stock, worth $4.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,340

Previous 142,730 6.73%

Holding current value

$4.35 Million

Previous $4.74 Million 1.6%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$27.94 - $35.91 $268,503 - $345,095	9,610 Added 6.73%	152,340 $4.81 Million
Q1 2025 May 15, 2025	BUY	$32.18 - $40.46 $633,302 - $796,252	19,680 Added 15.99%	142,730 $4.74 Million
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $973,800 - $1.3 Million	-32,460 Reduced 20.87%	123,050 $4.92 Million
Q1 2024 May 14, 2024	SELL	$29.93 - $35.06 $317,168 - $371,530	-10,597 Reduced 6.38%	155,510 $5.22 Million
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $380,678 - $669,756	19,827 Added 13.55%	166,107 $5.37 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $2.04 Million - $2.49 Million	63,910 Added 77.59%	146,280 $4.79 Million
Q2 2023 Aug 15, 2023	SELL	$30.5 - $37.4 $581,818 - $713,442	-19,076 Reduced 18.8%	82,370 $2.9 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $1.41 Million - $2.46 Million	45,623 Added 81.73%	101,446 $3.31 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $1.09 Million - $1.46 Million	23,977 Added 75.29%	55,823 $3.08 Million
Q3 2022 Nov 15, 2022	SELL	$42.06 - $55.45 $140,396 - $185,092	-3,338 Reduced 9.49%	31,846 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $119,033 - $185,080	3,549 Added 11.22%	35,184 $1.72 Million
Q1 2022 May 13, 2022	SELL	$33.14 - $51.13 $9,908 - $15,287	-299 Reduced 0.94%	31,635 $1.54 Million
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $771,593 - $993,858	22,634 Added 243.38%	31,934 $1.36 Million
Q3 2021 Nov 10, 2021	SELL	$25.68 - $38.61 $138,672 - $208,494	-5,400 Reduced 36.73%	9,300 $356,000
Q2 2021 Jul 30, 2021	BUY	$25.96 - $33.44 $381,612 - $491,567	14,700 New	14,700 $415,000

Others Institutions Holding HRMY

# of Institutions

291

Shares Held

46.3M

Call Options Held

316K

Put Options Held

69.9K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.69B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Harmony Biosciences Holdings, Inc. Transaction History